Literature DB >> 28874835

Pancreatic cancer: Exosomes for targeting KRAS in the treatment of pancreatic cancer.

Louis Buscail1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28874835     DOI： 10.1038/nrgastro.2017.113

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

2.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

Review 3.  Extracellular vesicles for drug delivery.

Authors:  Pieter Vader; Emma A Mol; Gerard Pasterkamp; Raymond M Schiffelers
Journal:  Adv Drug Deliv Rev       Date:  2016-02-27       Impact factor: 15.470

Review 4.  Roles for KRAS in pancreatic tumor development and progression.

Authors:  Marina Pasca di Magliano; Craig D Logsdon
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

5.  Mutant KRAS is a druggable target for pancreatic cancer.

Authors:  Elina Zorde Khvalevsky; Racheli Gabai; Itzhak Haim Rachmut; Elad Horwitz; Zivia Brunschwig; Ariel Orbach; Adva Shemi; Talia Golan; Abraham J Domb; Eylon Yavin; Hilla Giladi; Ludmila Rivkin; Alina Simerzin; Rami Eliakim; Abed Khalaileh; Ayala Hubert; Maor Lahav; Yael Kopelman; Eran Goldin; Alan Dancour; Yael Hants; Sagit Arbel-Alon; Rinat Abramovitch; Amotz Shemi; Eithan Galun
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

Review 6.  Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.

Authors:  Barbara Bournet; Camille Buscail; Fabrice Muscari; Pierre Cordelier; Louis Buscail
Journal:  Eur J Cancer       Date:  2015-12-28       Impact factor: 9.162

7.  TP53 loss creates therapeutic vulnerability in colorectal cancer.

Authors:  Yunhua Liu; Xinna Zhang; Cecil Han; Guohui Wan; Xingxu Huang; Cristina Ivan; Dahai Jiang; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Pulivarthi H Rao; Dipen M Maru; Andreas Pahl; Xiaoming He; Anil K Sood; Lee M Ellis; Jan Anderl; Xiongbin Lu
Journal:  Nature       Date:  2015-04-22       Impact factor: 49.962

8.  KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma.

Authors:  Barbara Bournet; Fabrice Muscari; Camille Buscail; Eric Assenat; Marc Barthet; Pascal Hammel; Janick Selves; Rosine Guimbaud; Pierre Cordelier; Louis Buscail
Journal:  Clin Transl Gastroenterol       Date:  2016-03-24       Impact factor: 4.488

9.  RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients.

Authors:  Talia Golan; Elina Zorde Khvalevsky; Ayala Hubert; Rachel Malka Gabai; Naama Hen; Amiel Segal; Abraham Domb; Gil Harari; Eliel Ben David; Stephen Raskin; Yuri Goldes; Eran Goldin; Rami Eliakim; Maor Lahav; Yael Kopleman; Alain Dancour; Amotz Shemi; Eithan Galun
Journal:  Oncotarget       Date:  2015-09-15

10.  Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.

Authors:  Sushrut Kamerkar; Valerie S LeBleu; Hikaru Sugimoto; Sujuan Yang; Carolina F Ruivo; Sonia A Melo; J Jack Lee; Raghu Kalluri
Journal:  Nature       Date:  2017-06-07       Impact factor: 49.962
  10 in total
  4 in total

1.  Protective role of small extracellular vesicles derived from HUVECs treated with AGEs in diabetic vascular calcification.

Authors:  Bei Guo; Su-Kang Shan; Feng Xu; Xiao Lin; Fu-Xing-Zi Li; Yi Wang; Qiu-Shuang Xu; Ming-Hui Zheng; Li-Min Lei; Chang-Chun Li; Zhi-Ang Zhou; Muhammad Hasnain Ehsan Ullah; Feng Wu; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  J Nanobiotechnology       Date:  2022-07-16       Impact factor: 9.429

Review 2.  A Review on Electroporation-Based Intracellular Delivery.

Authors:  Junfeng Shi; Yifan Ma; Jing Zhu; Yuanxin Chen; Yating Sun; Yicheng Yao; Zhaogang Yang; Jing Xie
Journal:  Molecules       Date:  2018-11-21       Impact factor: 4.411

Review 3.  Role of exosomes in pancreatic cancer.

Authors:  Hao Liu; Shishi Qiao; Xiaoyue Fan; Yufei Gu; Yingxuan Zhang; Shuai Huang
Journal:  Oncol Lett       Date:  2021-02-17       Impact factor: 2.967

Review 4.  Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Authors:  Ya-Nan Pi; Wen-Cai Qi; Bai-Rong Xia; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 8.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.